Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma

The aim of this study was to investigate whether the third-generation nitrogen-containing bisphosphonate (YM529) can inhibit the progression of established bone renal cell carcinoma (RCC) and to elucidate its mechanism. Antiproliferative effect and apoptosis induction of RCC cells and mouse osteocla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurabayashi, Atsushi, Inoue, Keiji, Fukuhara, Hideo, Karashima, Takashi, Fukata, Satoshi, Kawada, Chiaki, Shuin, Taro, Furihata, Mutsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556400/
https://www.ncbi.nlm.nih.gov/pubmed/26041278
http://dx.doi.org/10.1111/cas.12711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556400/
https://www.ncbi.nlm.nih.gov/pubmed/26041278
http://dx.doi.org/10.1111/cas.12711

Ejemplares similares